Faruqi & Faruqi, LLP Launches An Investigation Against The Clorox Company (CLX) For Potential Breaches Of Fiduciary Duties By Its Board Of Directors In The Manner It Seeks Executive Compensation Approval
Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of The Clorox Company (“Clorox” or the “Company”) (NYSE: CLX) for potential breaches of fiduciary duties in connection with their conduct in seeking shareholders’ approval of executive compensation and an amendment to the Company’s Stock Incentive Plan.
Specifically, in the Proxy Statement filed by the Company with the Securities and Exchange Commission on September 28, 2012, the Board of Directors recommends that Clorox’s shareholders vote to approve an amendment to the Company’s 2005 Stock Incentive Plan (the “2005 Plan”) to increase the number of shares that may be issued under the 2005 Plan by an additional 2,900,000 shares. The issuance of the additional shares could have a severe dilutive effect on the shares of Clorox common stock.
If you own common stock in Clorox and wish to obtain additional information and protect your investments free of charge, please contact Juan E. Monteverde, Esq. either via e-mail at email@example.com or by telephone at (877) 247-4292 or (212) 983-9330.
Please tell us about yourself by completing the form below and we will provide you with additional
information at no cost to you on how to join the Class Action.
* The submission of this form does not create an attorney-client relationship.
Faruqi & Faruqi, LLP
685 Third Avenue 26th Floor
New York, NY 10017
Tel: (212) 983-9330
If you have information regarding this case that you would like to make available, please click here to contact us about our investigation.